Recent Company News

• 02:35 AM ET Mar 26, 2026
  

  Denka Co. completes tender offer for Kainos Laboratories (¥2252.0000, 0)

• 09:43 PM ET Feb 26, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (133 total)

• 10:37 PM ET Feb 24, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (329 total)

• 10:22 PM ET Feb 18, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (204 total)

• 10:01 PM ET Feb 17, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (231 total)

• 10:14 PM ET Feb 16, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (174 total)

• 02:24 AM ET Feb 16, 2026
  

  Celltrion reports new data from post-hoc analysis of LIBERTY studies of subcutaneous infliximab for Crohn's disease and ulcerative colitis; to present the data at ECCO (KRW 238000.0000, 0)

• 10:14 PM ET Feb 15, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (211 total)

• 10:07 PM ET Feb 08, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (571 total)

• 05:57 AM ET Feb 06, 2026
  

  Denka to launch tender offer for Kainos at ¥2,285/share; Kainos holders including Hikari Tsuhin and Systemex Corp. agree to tender shares (¥1304.0000, 0)